Your browser doesn't support javascript.
loading
Molecular evidence for antigen drive in the natural history of mantle cell lymphoma.
Xochelli, Aliki; Sutton, Lesley-Ann; Agathangelidis, Andreas; Stalika, Evangelia; Karypidou, Maria; Marantidou, Fotini; Lopez, Alba Navarro; Papadopoulos, Giorgos; Supikova, Jana; Groenen, Patricia; Boudjogra, Myriam; Sundstrom, Christer; Ponzoni, Maurilio; Francova, Hana Skuhrova; Anagnostopoulos, Achilles; Pospisilova, Sarka; Papadaki, Theodora; Tzovaras, Dimitris; Ghia, Paolo; Pott, Christiane; Davi, Frederic; Campo, Elias; Rosenquist, Richard; Hadzidimitriou, Anastasia; Belessi, Chrysoula; Stamatopoulos, Kostas.
Afiliação
  • Xochelli A; Institute of Applied Biosciences, CERTH, Center for Research and Technology Hellas, Thessaloniki, Greece; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sw
  • Sutton LA; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. Electronic address: lesley.sutton@igp.uu.se.
  • Agathangelidis A; Laboratory of B cell Neoplasia and Lymphoma Unit, Division of Molecular Oncology and Department of Onco-Hematology, Università Vita-Salute San Raffaele, Milan, Italy.
  • Stalika E; Institute of Applied Biosciences, CERTH, Center for Research and Technology Hellas, Thessaloniki, Greece; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Karypidou M; Institute of Applied Biosciences, CERTH, Center for Research and Technology Hellas, Thessaloniki, Greece; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Marantidou F; Hematology Department, Nikea General Hospital, Piraeus, Greece.
  • Lopez AN; Insititut d'investigacions biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Papadopoulos G; Information Technologies Institute, CERTH, Center for Research and Technology Hellas, Thessaloniki, Greece.
  • Supikova J; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Groenen P; Department of Pathology, Radboud University, Nijmegen Medical Centre, Nijmegen, the Netherlands.
  • Boudjogra M; Biological Hematology Service, Hopital Pitie-Salpetriere, and UPMC Univ Paris 06, UMRS 1138, Paris, France.
  • Sundstrom C; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Ponzoni M; Pathology Unit and Unit of Lymphoid Malignancies, Istituto Scientifico San Raffaele, Milan, Italy.
  • Francova HS; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Anagnostopoulos A; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Pospisilova S; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Papadaki T; Hematopathology Department, Evangelismos Hospital, Athens, Greece.
  • Tzovaras D; Information Technologies Institute, CERTH, Center for Research and Technology Hellas, Thessaloniki, Greece.
  • Ghia P; Laboratory of B cell Neoplasia and Lymphoma Unit, Division of Molecular Oncology and Department of Onco-Hematology, Università Vita-Salute San Raffaele, Milan, Italy.
  • Pott C; II. Medizinische Klinik und Poliklinik, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Davi F; Biological Hematology Service, Hopital Pitie-Salpetriere, and UPMC Univ Paris 06, UMRS 1138, Paris, France.
  • Campo E; Insititut d'investigacions biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Rosenquist R; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Hadzidimitriou A; Institute of Applied Biosciences, CERTH, Center for Research and Technology Hellas, Thessaloniki, Greece.
  • Belessi C; Hematology Department, Nikea General Hospital, Piraeus, Greece.
  • Stamatopoulos K; Institute of Applied Biosciences, CERTH, Center for Research and Technology Hellas, Thessaloniki, Greece; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Am J Pathol ; 185(6): 1740-8, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25843681
ABSTRACT
To further our understanding about antigen involvement in mantle cell lymphoma (MCL), we analyzed the expression levels of activation-induced cytidine deaminase (AID), a key player in B-cell responses to antigen triggering, in 133 MCL cases; assessed the functionality of AID by evaluating in vivo class switch recombination in 52 MCL cases; and sought for indications of ongoing antigen interactions by exploring intraclonal diversification within 14 MCL cases. The AID full-length transcript and the most frequent splice variants (AID-ΔE4a, AID-ΔE) were detected in 128 (96.2%), 96 (72.2%), and 130 cases (97.7%), respectively. Higher AID full-length transcript levels were significantly associated (P < 0.001) with lack of somatic hypermutation within the clonotypic immunoglobulin heavy variable (IGHV) genes. Median AID transcript levels were higher in lymph node material compared to cases in which peripheral blood was analyzed, implying that clonal behavior is influenced by the microenvironment. Switched tumor-derived IGHV-IGHD-IGHJ transcripts were identified in 5 of 52 cases (9.6%), all of which displayed somatic hypermutation and AID-mRNA expression. Finally, although most cases exhibited low levels of intraclonal diversification, analysis of the mutational activity revealed a precise targeting of somatic hypermutation indicative of an active, ongoing interaction with antigen(s). Collectively, these findings strongly allude to antigen involvement in the natural history of MCL, further challenging the notion of antigen naivety.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Região Variável de Imunoglobulina / Linfócitos B / Linfoma de Célula do Manto / Citidina Desaminase / Hipermutação Somática de Imunoglobulina Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Am J Pathol Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Região Variável de Imunoglobulina / Linfócitos B / Linfoma de Célula do Manto / Citidina Desaminase / Hipermutação Somática de Imunoglobulina Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Am J Pathol Ano de publicação: 2015 Tipo de documento: Article